Expert articles to support every step of your journey.
Stopping GLP-1 without a plan leads to significant weight regain for most people. Here's the science-backed approach to keeping the weight off long-term.
The FLOW trial changed everything. GLP-1 doesn't just protect the heart — it actively preserves kidney function in people with diabetes and chronic kidney disease.
When GLP-1 kills your appetite so effectively that eating feels like a chore, these strategies help you meet your nutritional needs without force-feeding.
GLP-1 naturally reduces how much you eat — but eating too little is a real risk. Here's how to find the right calorie range for your body.
GLP-1 changes your appetite — but mindful eating practices transform how you relate to food permanently. Here's how to combine them.
Chronic inflammation drives heart disease, arthritis, cognitive decline, and cancer risk. GLP-1 directly reduces systemic inflammation — here's how.
PCOS and obesity have a complex, mutually reinforcing relationship. GLP-1 medications address both simultaneously. Here's what the research shows.
Weight regain after bariatric surgery is common. GLP-1 medications are increasingly used to address it — with strong evidence of effectiveness.
Mounjaro and Zepbound (tirzepatide) vs Ozempic and Wegovy (semaglutide) — both are excellent, but they work differently. Here's an honest comparison.
Most people on GLP-1 report dramatically reduced sugar cravings. But for some, sweet cravings persist. Here's the science and the strategies.
Obsessing over the scale misses the real transformation happening in your body and life. Learn to celebrate the victories that truly matter.
The number on the scale tells only part of the story. Understanding fat vs. muscle loss — and how to optimize your body composition — matters far more.